247 related articles for article (PubMed ID: 31264013)
21. MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques.
Wuesten O; Morelli JN; Miller MW; Tuzun E; Lenox MW; Fossum TW; Trelles M; Cotes C; Krombach GA; Runge VM
J Magn Reson Imaging; 2012 Nov; 36(5):1203-12. PubMed ID: 22826184
[TBL] [Abstract][Full Text] [Related]
22. [Influence of Different Contrast Agent Concentrations and Injection Protocols on Dynamic Contrast Enhanced MRI of Prostate: Equimolar Comparison of 1.0M Gadobutrol and 0.5M Gadolinium Chelates].
Makino Y; Akimoto S; Hoshino H
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(7):685-691. PubMed ID: 30033962
[TBL] [Abstract][Full Text] [Related]
23. Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging.
Fallenberg EM; Renz DM; Karle B; Schwenke C; Ingod-Heppner B; Reles A; Engelken FJ; Huppertz A; Hamm B; Taupitz M
Eur Radiol; 2015 Mar; 25(3):837-49. PubMed ID: 25249313
[TBL] [Abstract][Full Text] [Related]
24. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.
Radbruch A; Haase R; Kieslich PJ; Weberling LD; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Radiology; 2017 Mar; 282(3):699-707. PubMed ID: 27925871
[TBL] [Abstract][Full Text] [Related]
25. Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.
Clauser P; Helbich TH; Kapetas P; Pinker K; Bernathova M; Woitek R; Kaneider A; Baltzer PAT
J Magn Reson Imaging; 2019 Apr; 49(4):1157-1165. PubMed ID: 30552829
[TBL] [Abstract][Full Text] [Related]
26. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
27. Gadoxetate Disodium versus Gadoterate Meglumine: Quantitative Respiratory and Hemodynamic Metrics by Using Compressed-Sensing MRI.
Glessgen CG; Moor M; Stieltjes B; Winkel DJ; Block TK; Merkle EM; Heye TJ; Boll DT
Radiology; 2019 Nov; 293(2):317-326. PubMed ID: 31549944
[TBL] [Abstract][Full Text] [Related]
28. Comparison of inner ear MRI enhancement in patients with Meniere's disease after intravenous injection of gadobutrol, gadoterate meglumine, or gadodiamide.
Xie J; Zhang W; Zhu J; Hui L; Li S; Zhang B
Eur J Radiol; 2021 Jun; 139():109682. PubMed ID: 33813284
[TBL] [Abstract][Full Text] [Related]
29. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
[TBL] [Abstract][Full Text] [Related]
30. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
Pozeg P; Forget J; Meuli RA; Maeder P
Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
[TBL] [Abstract][Full Text] [Related]
31. Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI.
Khouri Chalouhi K; Papini GDE; Bandirali M; Sconfienza LM; Di Leo G; Sardanelli F
Eur J Radiol; 2014 Jul; 83(7):1245-1249. PubMed ID: 24816087
[TBL] [Abstract][Full Text] [Related]
32. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
[TBL] [Abstract][Full Text] [Related]
33. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
34. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
Bussi S; Coppo A; Bonafè R; Rossi S; Colombo Serra S; Penard L; Kirchin MA; Maisano F; Tedoldi F
J Magn Reson Imaging; 2021 Nov; 54(5):1636-1644. PubMed ID: 33973290
[TBL] [Abstract][Full Text] [Related]
35. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T.
Wildgruber M; Stadlbauer T; Rasper M; Hapfelmeier A; Zelger O; Eckstein HH; Halle M; Rummeny EJ; Huber AM
Invest Radiol; 2014 Nov; 49(11):728-34. PubMed ID: 24872002
[TBL] [Abstract][Full Text] [Related]
36. The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).
Vaneckova M; Herman M; Smith MP; Mechl M; Maravilla KR; Weichet J; Spampinato MV; Žižka J; Wippold FJ; Baima JJ; Babbel R; Bültmann E; Huang RY; Buhk JH; Bonafé A; Colosimo C; Lui S; Kirchin MA; Shen N; Pirovano G; Spinazzi A
AJNR Am J Neuroradiol; 2015 Sep; 36(9):1589-98. PubMed ID: 26185325
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 0.5 M gadoterate and 1.0 M gadobutrol in peripheral MRA: a prospective, single-center, randomized, crossover, double-blind study.
Haneder S; Attenberger UI; Schoenberg SO; Loewe C; Arnaiz J; Michaely HJ
J Magn Reson Imaging; 2012 Nov; 36(5):1213-21. PubMed ID: 22848033
[TBL] [Abstract][Full Text] [Related]
38. 1.0-M gadobutrol versus 0.5-M gadoterate for peripheral magnetic resonance angiography: a prospective randomized controlled clinical trial.
Szucs-Farkas Z; Froehlich JM; Ulrich M; Wuersten HU; Guignard D; Wyss S; Braunschweig M
J Magn Reson Imaging; 2008 Jun; 27(6):1399-405. PubMed ID: 18504760
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
